Vibriosis due to Vibrio vulnificus serovar E (biotype 2) is one of the main causes of mortality in European eels cultured in Europe. The main objective of this study was to develop a vaccine and a vaccination procedure against this pathogen. With this aim, we tested several vaccine formulations (inactivated whole-cells with and without toxoids -inactivated extracellular products -from capsulated and uncapsulated strains, attenuated live vaccines and purified lipopolysaccharide [LPS]) on eels maintained under controlled laboratory conditions using different delivery routes (injection and immersion). To study the immune response we estimated antibody titers and bactericidal/bacteriostatic activity in mucus and serum. To evaluate protection, we calculated the relative percent survival (RPS) after intraperitoneal (i.p.) injection and bath challenge of the pathogen. The overall results indicate that: (1) capsular antigens seem to be essential for protective immunization; (2) vaccines confer the highest protection when administered by i.p. injection; (3) booster is needed to achieve good protection by immersion; (4) enriching the vaccine with toxoids enhances protection to optimal levels (RPS values around 70 to 100%, depending on the delivery route); and (5) the protective effect in serum and mucus depends on the route of administration and seems to be related to the production of specific antibodies.
KEY WORDS: Vibrio vulnificus serovar E · Vibrio vulnificus biotype 2 · Eel vaccines · Vibrio vaccines · Vaccination by injection · Vaccination by prolonged immersion
Resale or republication not permitted without written consent of the publisherDis Aquat Org 43: [91][92][93][94][95][96][97][98][99][100][101] 2000 Vibrio vulnificus serovar E is an opportunistic human pathogen (Amaro & Biosca 1996) which is able to survive and spread infection through water (Amaro et al. 1995).To make eel culture profitable, in both brackish and fresh water, alternative strategies are needed to solve the problem, and should focus mainly on preventative measures. The use of vaccines in aquaculture has been shown to successfully protect fish against bacterial diseases, such as vibriosis (caused by Listonella anguillarum [formerly Vibrio anguillarum] and V. ordalii ), edwardsiellosis, furunculosis, streptococcosis and pasteurellosis (Song et al. 1982, Austin 1983, Larsen 1988, Smith 1988, Dec et al. 1990, Roogers & Xu 1992, Magariños et al. 1994, Quentel & Ogier de Baulny 1995, Toranzo et al. 1995, Romalde et al. 1996, Gravningen et al. 1998. In particular, the success achieved in immunization against other vibrioses (Smith 1988) suggests that the best solution would be an effective vaccine against V. vulnificus. Although numerous vaccines against other vibrioses have been developed and licensed to date, no vaccine against V. vulnificus serovar E is available at present. The main objective of this study was to develop a vaccine and a vaccination procedure against this pathogen. With this aim, we tested several vaccine formulatio...